Trademark Clearinghouse passes 5,000 registrations

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Trademark Clearinghouse passes 5,000 registrations

Cosmetics and pharmaceutical companies have not yet made extensive use of Icann’s Trademark Clearinghouse, which can help to protect brands from cybersquatting in the new gTLDs

According to information published today, there have so far been 5,000 registrations in the Clearinghouse.

But only 1% of marks relate to cosmetics, and just 0.8% cover pharmaceutical and medical products.

Less than 10% of the marks in the Clearinghouse so far relate to clothing and footwear, while 23% are for scientific or teaching apparatus, 22% for advertising or business management and 16% relate to sporting equipment.

The breakdown of marks is based on the Nice classification.

The US is the biggest source of Clearinghouse applications, making up 44%. France accounts for 10%, the UK for 7% and Germany for 4%.

Almost two-third of the records are registered for only one year.

Icann is holding a public meeting in Durban, South Africa this week at which further discussions on the gTLD rollout and other IP protection mechanisms are taking place.

Yesterday, Icann signed four new gTLD agreements, all of them with operators of TLDs in non-western scripts.

more from across site and SHARED ros bottom lb

More from across our site

Emma Green, partner at Bird & Bird, shares why the Iceland v Iceland dispute could prompt businesses and lawyers to think differently about brand enforcement
Attain IP, developed by two UK patent lawyers, will meet ‘forensic’ needs of patent attorneys by showing a verifiable reasoning chain, according to its co-founders
The High Court of Australia has allowed a fashion designer to retain her registered ‘Katie Perry’ trademark for clothing
Sim & San secured the win for Dr. Reddy’s, which will allow the pharma company to manufacture and export semaglutide, the active ingredient in Ozempic
Lucas Amodio joins our ‘Five minutes with’ series to discuss artificial intelligence systems and patent law
The Americas research cycle has commenced, so don't miss the opportunity to submit your work
Practitioners have welcomed extended funding of the specialist police unit until 2029, while the UKIPO says it is exploring increased scale
Abion says integration with Baylos marks an important step in the company’s international expansion plans
Via Licensing Alliance continues its China push as another smartphone manufacturer joins patent pool as licensee
Law firm mergers have the potential to reshape IP teams, and partners who were at the coalface of previous tie-ups say early coordination and flexibility can make the difference
Gift this article